Quick Muscle™ Skeletal – SeV Kit

Quick-Muscle™ Skeletal – SeV Kits enable the differentiation of human pluripotent stem cells into skeletal muscle cells using Sendai virus technology through an optimized and reproducible workflow.

Note: This kit is no longer available for individual sale. We now offer bulk orders and custom differentiation services to support your research and development needs.

Advantages of iPSC-Derived Skeletal Muscle

Rapid Differentiation
~1 week
Optimized & Reproducible
ISO-9001 certified
Highly Pure Population
MHC+
No Genetic Footprint
0 modifications

Skeletal Muscle Differentiation Kit Protocol

Our easy-to-follow, optimized skeletal muscle differentiation protocol supports rapid and reproducible differentiation of human induced pluripotent stem cells (iPSCs) into functional skeletal muscle. This step-by-step workflow outlines the key culture stages and timelines for generating skeletal muscle cells from human iPSCs, giving researchers a scalable, reproducible platform for muscle disease modeling, compound screening, and more.

Skeletal muscle differentiation protocol workflow timeline
Phase contrast images of skeletal muscle cell cultures across days 1 to 6 post-differentiation
Skeletal muscle morphology is confirmed via phase contrast imagery. Representative phase contrast images of Quick Muscle™ Skeletal – SeV Kit cell cultures on days 1-6 post-differentiation (scale bar = 100 μm).

Skeletal Muscle Characterization

Rigorous post-differentiation characterization of our iPSC-derived skeletal muscle cells ensures identity, purity, and functional relevance. Using skeletal muscle–specific markers and phenotypic profiling, we confirm cell lineage and batch-to-batch consistency.

Skeletal Muscle Marker Expression

Expression of skeletal muscle–specific markers is evaluated post-differentiation to verify identity, purity, and maturation status. Using protein-level analyses, we confirm robust expression of myosin heavy chain (MHC), a canonical marker of the contractile apparatus in differentiated skeletal myocytes, to ensure batch-to-batch consistency and experimental reliability.

Merged ICC image of skeletal muscle cells
Merge
MHC ICC image of skeletal muscle cells
MHC
Hoechst ICC image of skeletal muscle cells
Hoechst

iPSC-derived skeletal muscle cells express key markers and display typical morphology. Immunofluorescent staining of Quick-Muscle™ Skeletal cells shows typical skeletal muscle cell morphology and MHC expression. Immunofluorescent staining of Quick-Muscle™ Skeletal – mRNA cell cultures on day 6 post-differentiation show expression of myosin heavy chain (scale bar = 100 μm).

Product Specifications

Parameters Specifications
Product Name Quick-Muscle™ Skeletal - SeV Kit
Catalog No. SM-SeV
Product Components QMS-SeV, Mesendoderm RNA, Component P, and Coating Material A
Storage Conditions SeV should be stored at -80°C. All other components can be stored at -20°C or -80°C.
Cell Type Skeletal Muscle
Induction Method Transcription factors delivered by Sendai virus
Differentiation At day 7 post-differentiation (CW50065)
>70% of cells express MHC positive cells
Sterility No growth observed
Mycoplasma No DNA detected
Restricted Use For research use only. Not for use in diagnostic or therapeutic procedures.